BioSight
Companies
TEVA PHARMACEUTICAL INDUSTRIES LTD logo

TEVA

NYSETEL AVIV
TEVA PHARMACEUTICAL INDUSTRIES LTD

Teva Pharmaceutical Industries Limited is a global pharmaceutical company with a portfolio spanning generic medicines, innovative pharmaceuticals, and biosimilars across therapeutic areas including neurology, oncology, specialty care, and respiratory. The company markets commercial-stage products across multiple modalities including small molecules and biologics, while maintaining a pipeline of innovative and biosimilar candidates aimed at expanding its specialty and branded medicine offerings. Teva's strategy focuses on balancing its established generic medicines business with growth in higher-margin innovative and biosimilar products through organic development and business development initiatives.

$34.95+123.75%1Y
TEVA · daily close · illustrative · 0 catalysts marked
$13$20$26$32$38May '25Aug '25Dec '25May '26
1Y high$36.251Y low$15.38range$20.87(136%)past catalysts

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar